Selected research
Industry Growth & Trends
Global IVD CDMO Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global IVD CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for IVD CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for IVD CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for IVD CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the IVD CDMO market include Hitachi, Canon, TE Connectivity, JEOL, HU Group, DCN DX, Stevanato, Argonaut and Erreka, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global IVD CDMO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The IVD CDMO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IVD CDMO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IVD CDMO.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global IVD CDMO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
IVD CDMO Market by Company
Hitachi
Canon
TE Connectivity
JEOL
HU Group
DCN DX
Stevanato
Argonaut
Erreka
GBC
Phillips Medisize
AIVD Biotech
Kaishi Biological Technology
Keysmile Biological Technology
Nabai Medical Technology
Hochuen Medical
IVD CDMO Segment by Type
Molecular Diagnosis
Immunodiagnosis
Biochemical Diagnosis
Other
IVD CDMO Segment by Application
Instruments
Consumables
IVD CDMO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVD CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of IVD CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVD CDMO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of IVD CDMO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Molecular Diagnosis
- Immunodiagnosis
- Biochemical Diagnosis
- Other
Applications
- Instruments
- Consumables
Companies covered
- Hitachi
- Canon
- TE Connectivity
- JEOL
- HU Group
- DCN DX
- Stevanato
- Argonaut
- Erreka
- GBC
- Phillips Medisize
- AIVD Biotech
- Kaishi Biological Technology
- Keysmile Biological Technology
- Nabai Medical Technology
- Hochuen Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global IVD CDMO Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global IVD CDMO Market Size by Region (2021-2032)
- 1.4.1 Global IVD CDMO Market Size by Region (2021-2026)
- 1.4.2 Global IVD CDMO Market Size by Region (2027-2032)
- 1.5 Key Regions IVD CDMO Market Size (2021-2032)
- 1.5.1 North America IVD CDMO Market Size Growth Rate (2021-2032)
- 1.5.2 Europe IVD CDMO Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific IVD CDMO Market Size Growth Rate (2021-2032)
- 1.5.4 South America IVD CDMO Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa IVD CDMO Market Size Growth Rate (2021-2032)
2 IVD CDMO Market by Type
- 2.1 Type Introduction
- 2.1.1 Molecular Diagnosis
- 2.1.2 Immunodiagnosis
- 2.1.3 Biochemical Diagnosis
- 2.1.4 Other
- 2.2 Global IVD CDMO Market Size by Type
- 2.2.1 Global IVD CDMO Market Size Overview by Type (2021-2032)
- 2.2.2 Global IVD CDMO Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global IVD CDMO Market Size Forecasted by Type (2027-2032)
- 2.3 Global IVD CDMO Market Size by Regions
- 2.3.1 North America IVD CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe IVD CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific IVD CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America IVD CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa IVD CDMO Market Size Breakdown by Type (2021-2026)
3 IVD CDMO Market by Application
- 3.1 Type Introduction
- 3.1.1 Instruments
- 3.1.2 Consumables
- 3.2 Global IVD CDMO Market Size by Application
- 3.2.1 Global IVD CDMO Market Size Overview by Application (2021-2032)
- 3.2.2 Global IVD CDMO Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global IVD CDMO Market Size Forecasted by Application (2027-2032)
- 3.3 Global IVD CDMO Market Size by Regions
- 3.3.1 North America IVD CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe IVD CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific IVD CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America IVD CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa IVD CDMO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 IVD CDMO Industry Trends
- 4.2 IVD CDMO Industry Drivers
- 4.3 IVD CDMO Industry Opportunities and Challenges
- 4.4 IVD CDMO Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by IVD CDMO Revenue (2021-2026)
- 5.2 Global IVD CDMO Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global IVD CDMO Key Company Headquarters & Area Served
- 5.4 Global IVD CDMO Company, Product Type & Application
- 5.5 Global IVD CDMO Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global IVD CDMO Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 IVD CDMO Players Market Share by Revenue in 2025
- 5.6.3 2025 IVD CDMO Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Hitachi
- 6.1.1 Hitachi Company Information
- 6.1.2 Hitachi Business Overview
- 6.1.3 Hitachi IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Hitachi IVD CDMO Product Portfolio
- 6.1.5 Hitachi Recent Developments
- 6.2 Canon
- 6.2.1 Canon Company Information
- 6.2.2 Canon Business Overview
- 6.2.3 Canon IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Canon IVD CDMO Product Portfolio
- 6.2.5 Canon Recent Developments
- 6.3 TE Connectivity
- 6.3.1 TE Connectivity Company Information
- 6.3.2 TE Connectivity Business Overview
- 6.3.3 TE Connectivity IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 TE Connectivity IVD CDMO Product Portfolio
- 6.3.5 TE Connectivity Recent Developments
- 6.4 JEOL
- 6.4.1 JEOL Company Information
- 6.4.2 JEOL Business Overview
- 6.4.3 JEOL IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 JEOL IVD CDMO Product Portfolio
- 6.4.5 JEOL Recent Developments
- 6.5 HU Group
- 6.5.1 HU Group Company Information
- 6.5.2 HU Group Business Overview
- 6.5.3 HU Group IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 HU Group IVD CDMO Product Portfolio
- 6.5.5 HU Group Recent Developments
- 6.6 DCN DX
- 6.6.1 DCN DX Company Information
- 6.6.2 DCN DX Business Overview
- 6.6.3 DCN DX IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 DCN DX IVD CDMO Product Portfolio
- 6.6.5 DCN DX Recent Developments
- 6.7 Stevanato
- 6.7.1 Stevanato Company Information
- 6.7.2 Stevanato Business Overview
- 6.7.3 Stevanato IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Stevanato IVD CDMO Product Portfolio
- 6.7.5 Stevanato Recent Developments
- 6.8 Argonaut
- 6.8.1 Argonaut Company Information
- 6.8.2 Argonaut Business Overview
- 6.8.3 Argonaut IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Argonaut IVD CDMO Product Portfolio
- 6.8.5 Argonaut Recent Developments
- 6.9 Erreka
- 6.9.1 Erreka Company Information
- 6.9.2 Erreka Business Overview
- 6.9.3 Erreka IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Erreka IVD CDMO Product Portfolio
- 6.9.5 Erreka Recent Developments
- 6.10 GBC
- 6.10.1 GBC Company Information
- 6.10.2 GBC Business Overview
- 6.10.3 GBC IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 GBC IVD CDMO Product Portfolio
- 6.10.5 GBC Recent Developments
- 6.11 Phillips Medisize
- 6.11.1 Phillips Medisize Company Information
- 6.11.2 Phillips Medisize Business Overview
- 6.11.3 Phillips Medisize IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Phillips Medisize IVD CDMO Product Portfolio
- 6.11.5 Phillips Medisize Recent Developments
- 6.12 AIVD Biotech
- 6.12.1 AIVD Biotech Company Information
- 6.12.2 AIVD Biotech Business Overview
- 6.12.3 AIVD Biotech IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 AIVD Biotech IVD CDMO Product Portfolio
- 6.12.5 AIVD Biotech Recent Developments
- 6.13 Kaishi Biological Technology
- 6.13.1 Kaishi Biological Technology Company Information
- 6.13.2 Kaishi Biological Technology Business Overview
- 6.13.3 Kaishi Biological Technology IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Kaishi Biological Technology IVD CDMO Product Portfolio
- 6.13.5 Kaishi Biological Technology Recent Developments
- 6.14 Keysmile Biological Technology
- 6.14.1 Keysmile Biological Technology Company Information
- 6.14.2 Keysmile Biological Technology Business Overview
- 6.14.3 Keysmile Biological Technology IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Keysmile Biological Technology IVD CDMO Product Portfolio
- 6.14.5 Keysmile Biological Technology Recent Developments
- 6.15 Nabai Medical Technology
- 6.15.1 Nabai Medical Technology Company Information
- 6.15.2 Nabai Medical Technology Business Overview
- 6.15.3 Nabai Medical Technology IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Nabai Medical Technology IVD CDMO Product Portfolio
- 6.15.5 Nabai Medical Technology Recent Developments
- 6.16 Hochuen Medical
- 6.16.1 Hochuen Medical Company Information
- 6.16.2 Hochuen Medical Business Overview
- 6.16.3 Hochuen Medical IVD CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Hochuen Medical IVD CDMO Product Portfolio
- 6.16.5 Hochuen Medical Recent Developments
7 North America
- 7.1 North America IVD CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America IVD CDMO Market Size by Country (2021-2026)
- 7.3 North America IVD CDMO Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe IVD CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe IVD CDMO Market Size by Country (2021-2026)
- 8.3 Europe IVD CDMO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific IVD CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific IVD CDMO Market Size by Country (2021-2026)
- 9.3 Asia-Pacific IVD CDMO Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America IVD CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America IVD CDMO Market Size by Country (2021-2026)
- 10.3 South America IVD CDMO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa IVD CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa IVD CDMO Market Size by Country (2021-2026)
- 11.3 Middle East & Africa IVD CDMO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst